Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simone Bini

Showing results (21-30 of 35) with videos related to

Pageof 4
Sort By:
European Journal of Preventive Cardiology|February 20, 2024
Contemporary lipid-lowering management and risk of cardiovascular events in homozygous familial hypercholesterolaemia: insights from the Italian LIPIGEN RegistryLaura D'Erasmo, Simone Bini, Manuela Casula, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|September 26, 2022
Differential effects of bariatric surgery on plasma levels of ANGPTL3 and ANGPTL4Simone Bini, Laura D'Erasmo, Brenno Astiarraga, et al.
Drugs|March 19, 2025
Renal Safety Assessment of Lipid-Lowering Drugs: Between Old Certainties and New QuestionsDaniele Tramontano, Simone Bini, Carlo Maiorca, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|January 19, 2026
Low Cholesterol due to APOB Variants: Exploring the Balance Between Liver and Cardiovascular RiskAlessia Di Costanzo, Ilaria Pirona, Silvia Buonaiuto, et al.
Atherosclerosis|March 8, 2025
The vicious circle of chronic kidney disease and hypertriglyceridemia: What is first, the hen or the egg?Daniele Tramontano, Laura D'Erasmo, Miriam Larouche, et al.
Journal of Clinical Lipidology|November 10, 2021
Refinement of pathogenicity classification of variants associated with familial hypercholesterolemia: Implications for clinical diagnosisAlessia Di Costanzo, Ilenia Minicocci, Laura D'Erasmo, et al.
Journal of the American College of Cardiology|October 4, 2024
Effect of Cholesterol-Lowering Variants in ANGPTL3 and APOB Genes on Liver DiseaseAlessia Di Costanzo, Ilaria Pirona, Silvia Buonaiuto, et al.
Atherosclerosis|February 6, 2026
The hidden burden of kidney damage in chylomicronemia syndromesLaura D'Erasmo, Daniele Tramontano, Alessia Di Costanzo, et al.
Frontiers in Genetics|September 8, 2022
Efficacy of Long-Term Treatment of Autosomal Recessive Hypercholesterolemia With Lomitapide: A Subanalysis of the Pan-European Lomitapide StudyLaura D'Erasmo, Antonina Giammanco, Patrizia Suppressa, et al.
Cancers|September 23, 2022
Surgical Resection Is Superior to TACE in the Treatment of HCC in a Well Selected Cohort of BCLC-B Elderly Patients-A Retrospective Observational StudyStefania Brozzetti, Chiara D'Alterio, Simone Bini, et al.
Pageof 4

Showing results (21-30 of 35) with videos related to

Sort By:
Pageof 4
European Journal of Preventive Cardiology|February 20, 2024
Contemporary lipid-lowering management and risk of cardiovascular events in homozygous familial hypercholesterolaemia: insights from the Italian LIPIGEN RegistryLaura D'Erasmo, Simone Bini, Manuela Casula, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|September 26, 2022
Differential effects of bariatric surgery on plasma levels of ANGPTL3 and ANGPTL4Simone Bini, Laura D'Erasmo, Brenno Astiarraga, et al.
Drugs|March 19, 2025
Renal Safety Assessment of Lipid-Lowering Drugs: Between Old Certainties and New QuestionsDaniele Tramontano, Simone Bini, Carlo Maiorca, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|January 19, 2026
Low Cholesterol due to APOB Variants: Exploring the Balance Between Liver and Cardiovascular RiskAlessia Di Costanzo, Ilaria Pirona, Silvia Buonaiuto, et al.
Atherosclerosis|March 8, 2025
The vicious circle of chronic kidney disease and hypertriglyceridemia: What is first, the hen or the egg?Daniele Tramontano, Laura D'Erasmo, Miriam Larouche, et al.
Journal of Clinical Lipidology|November 10, 2021
Refinement of pathogenicity classification of variants associated with familial hypercholesterolemia: Implications for clinical diagnosisAlessia Di Costanzo, Ilenia Minicocci, Laura D'Erasmo, et al.
Journal of the American College of Cardiology|October 4, 2024
Effect of Cholesterol-Lowering Variants in ANGPTL3 and APOB Genes on Liver DiseaseAlessia Di Costanzo, Ilaria Pirona, Silvia Buonaiuto, et al.
Atherosclerosis|February 6, 2026
The hidden burden of kidney damage in chylomicronemia syndromesLaura D'Erasmo, Daniele Tramontano, Alessia Di Costanzo, et al.
Frontiers in Genetics|September 8, 2022
Efficacy of Long-Term Treatment of Autosomal Recessive Hypercholesterolemia With Lomitapide: A Subanalysis of the Pan-European Lomitapide StudyLaura D'Erasmo, Antonina Giammanco, Patrizia Suppressa, et al.
Cancers|September 23, 2022
Surgical Resection Is Superior to TACE in the Treatment of HCC in a Well Selected Cohort of BCLC-B Elderly Patients-A Retrospective Observational StudyStefania Brozzetti, Chiara D'Alterio, Simone Bini, et al.
Pageof 4